Results 41 to 50 of about 87,047 (325)

Phase II evaluation of VDC-1101 in canine cutaneous T-cell lymphoma. [PDF]

open access: yes, 2014
BackgroundCanine cutaneous T-cell lymphoma (CTCL) is an uncommon disease for which efficacious therapies are lacking. The novel anticancer nucleotide prodrug VDC-1101 (formerly known as GS-9219) has shown efficacy in dogs with multicentric lymphoma.
Burgess, KE   +5 more
core   +2 more sources

Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis [PDF]

open access: yes, 2008
Terbinafine, a synthetic allylamine, exerts fungicidal activity against dermatophytes, the causative pathogens of tinea pedis. As proven in numerous clinical trials, tinea pedis can be effectively and safely treated by topical terbinafine.
Korting, Hans Christian   +2 more
core   +1 more source

Subcutaneous mycoses in a tertiary care hospital in India: Pathologist’s perspective

open access: yesJournal of Current Research in Scientific Medicine, 2023
Background: Subcutaneous mycoses, a disease of the tropics, are usually missed or misdiagnosed in immunocompetent individuals unless sought for. The study was designed to explore the experience of diagnosing subcutaneous mycoses by histopathological ...
Rajeshwari Kumaravel Muthusamy   +2 more
doaj   +1 more source

The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome

open access: yesActa Dermato-Venereologica, 2019
It is difficult to distinguish erythrodermic mycosis fungoides from Sézary syndrome due to their similar clinical and histological features. The main purpose of this study was to investigate whether microRNA expression profiles in lesional skin could ...
Anne Hald Rittig   +6 more
doaj   +1 more source

Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study

open access: yesBritish Journal of Dermatology, 2019
Mycosis fungoides (MF) and Sézary Syndrome (SS) are the most common cutaneous T‐cell lymphomas. MF/SS is accompanied by considerable morbidity from pain, itching and disfigurement.
K. Molloy   +36 more
semanticscholar   +1 more source

Blastomycosis—Some Progress but Still Much to Learn

open access: yesJournal of Fungi, 2022
Blastomycosis, caused by Blastomyces spp., is an endemic mycosis capable of causing significant disease throughout the body. Higher rates of infection are seen in the Mississippi and Ohio River valleys, the Great Lakes region of the United States and ...
Matthew F. Pullen   +2 more
doaj   +1 more source

Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis

open access: yesFrontiers in Microbiology, 2017
The high rates of morbidity and mortality caused by fungal infections are associated with the current limited antifungal arsenal and the high toxicity of the compounds.
L. Scorzoni   +8 more
semanticscholar   +1 more source

Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome [PDF]

open access: yes, 2018
Cutaneous T-cell lymphoma is a group of incurable extranodal non-Hodgkin lymphomas that develop from the skin-homing CD4+ T cell. Mycosis fungoides and Sézary syndrome are the most common histological subtypes.
Benucci, Roberto   +9 more
core   +2 more sources

Topical Application of Imiquimod as a Treatment for Chromoblastomycosis [PDF]

open access: yes, 2014
Peer reviewedPublisher ...
Belda Junior, Walter   +7 more
core   +1 more source

Lymph node detection of monoclonal T-cell population correlates with poorer prognosis in mycosis fungoides and Sèzary syndrome. [PDF]

open access: yesBr J Haematol
British Journal of Haematology, Volume 207, Issue 4, Page 1604-1608, October 2025.
Miyashiro D   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy